These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 16503879

  • 1. Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIa.
    Varfaj F, Neuberg J, Jenkins PV, Wakabayashi H, Fay PJ.
    Biochem J; 2006 Jun 01; 396(2):355-62. PubMed ID: 16503879
    [Abstract] [Full Text] [Related]

  • 2. Residues surrounding Arg336 and Arg562 contribute to the disparate rates of proteolysis of factor VIIIa catalyzed by activated protein C.
    Varfaj F, Wakabayashi H, Fay PJ.
    J Biol Chem; 2007 Jul 13; 282(28):20264-72. PubMed ID: 17519239
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activated protein C-catalyzed inactivation of human factor VIII and factor VIIIa. Identification of cleavage sites and correlation of proteolysis with cofactor activity.
    Fay PJ, Smudzin TM, Walker FJ.
    J Biol Chem; 1991 Oct 25; 266(30):20139-45. PubMed ID: 1939075
    [Abstract] [Full Text] [Related]

  • 6. Factor IXa protects factor VIIIa from activated protein C. Factor IXa inhibits activated protein C-catalyzed cleavage of factor VIIIa at Arg562.
    Regan LM, Lamphear BJ, Huggins CF, Walker FJ, Fay PJ.
    J Biol Chem; 1994 Apr 01; 269(13):9445-52. PubMed ID: 8144529
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Exosite-dependent regulation of factor VIIIa by activated protein C.
    Manithody C, Fay PJ, Rezaie AR.
    Blood; 2003 Jun 15; 101(12):4802-7. PubMed ID: 12595311
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V.
    Gale AJ, Cramer TJ, Rozenshteyn D, Cruz JR.
    J Biol Chem; 2008 Jun 13; 283(24):16355-62. PubMed ID: 18424440
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
    Egan JO, Kalafatis M, Mann KG.
    Protein Sci; 1997 Sep 13; 6(9):2016-27. PubMed ID: 9300501
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V.
    Lu D, Kalafatis M, Mann KG, Long GL.
    Blood; 1996 Jun 01; 87(11):4708-17. PubMed ID: 8639840
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa.
    Wakabayashi H, Fay PJ.
    J Biol Chem; 2008 Apr 25; 283(17):11645-51. PubMed ID: 18299331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.